Cen Y - Search Results

1

Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.

Xu J, Fang Y, Chen K, Li S, Tang S, Ren Y, Cen Y, Fei W, Zhang B, Shen Y, Lu W. Xu J, et al. Among authors: cen y. Clin Cancer Res. 2022 Aug 15;28(16):3590-3602. doi: 10.1158/1078-0432.CCR-22-0296. Clin Cancer Res. 2022. PMID: 35675036 Free PMC article.

2

CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.

Zhang Y, Zhao L, Yang S, Cen Y, Zhu T, Wang L, Xia L, Liu Y, Zou J, Xu J, Li Y, Cheng X, Lu W, Wang X, Xie X. Zhang Y, et al. Among authors: cen y. J Exp Clin Cancer Res. 2020 Dec 11;39(1):281. doi: 10.1186/s13046-020-01793-7. J Exp Clin Cancer Res. 2020. PMID: 33308298 Free PMC article.

3

hsa_circ_0005358 suppresses cervical cancer metastasis by interacting with PTBP1 protein to destabilize CDCP1 mRNA.

Cen Y, Zhu T, Zhang Y, Zhao L, Zhu J, Wang L, Xu J, Ding T, Xie X, Wang X, Lu W. Cen Y, et al. Mol Ther Nucleic Acids. 2021 Nov 29;27:227-240. doi: 10.1016/j.omtn.2021.11.020. eCollection 2022 Mar 8. Mol Ther Nucleic Acids. 2021. PMID: 34976440 Free PMC article.

4

Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer.

Cen Y, Fang Y, Ren Y, Hong S, Lu W, Xu J. Cen Y, et al. Cell Death Dis. 2022 Apr 13;13(4):342. doi: 10.1038/s41419-022-04807-8. Cell Death Dis. 2022. PMID: 35418185 Free PMC article.

5

Oncogenic circTICRR suppresses autophagy via binding to HuR protein and stabilizing GLUD1 mRNA in cervical cancer.

Zhu T, Cen Y, Chen Z, Zhang Y, Zhao L, Wang J, Lu W, Xie X, Wang X. Zhu T, et al. Among authors: cen y. Cell Death Dis. 2022 May 20;13(5):479. doi: 10.1038/s41419-022-04943-1. Cell Death Dis. 2022. PMID: 35595754 Free PMC article.

6

[IL-1β inhibitor sensitizes to olaparib in homologous recombination deficiency proficient ovarian cancer cells].

Xu JF, Cen YX, Tang SS, Ren Y, Lyu WG. Xu JF, et al. Among authors: cen yx. Zhonghua Fu Chan Ke Za Zhi. 2022 Jul 25;57(7):519-529. doi: 10.3760/cma.j.cn112141-20220509-00307. Zhonghua Fu Chan Ke Za Zhi. 2022. PMID: 35902786 Chinese.

7

The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma.

Shen Y, Ren Y, Chen K, Cen Y, Zhang B, Lu W, Xu J. Shen Y, et al. Among authors: cen y. Oncogenesis. 2022 Jul 30;11(1):43. doi: 10.1038/s41389-022-00419-1. Oncogenesis. 2022. PMID: 35907904 Free PMC article.

8

Breaking the Iron Homeostasis: A "Trojan Horse" Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition.

Li Y, Cen Y, Fang Y, Tang S, Li S, Ren Y, Zhang H, Lu W, Xu J. Li Y, et al. Among authors: cen y. ACS Nano. 2022 Aug 23;16(8):12786-12800. doi: 10.1021/acsnano.2c04956. Epub 2022 Aug 3. ACS Nano. 2022. PMID: 35920396 Free PMC article.

9

Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation.

Li S, Shen S, Ge W, Cen Y, Zhang S, Cheng X, Wang X, Xie X, Lu W. Li S, et al. Among authors: cen y. Biomark Res. 2023 Jan 30;11(1):12. doi: 10.1186/s40364-022-00432-x. Biomark Res. 2023. PMID: 36717926 Free PMC article.

10

Nanoengineered Gallium Ion Incorporated Formulation for Safe and Efficient Reversal of PARP Inhibition and Platinum Resistance in Ovarian Cancer.

Li Y, Cen Y, Tu M, Xiang Z, Tang S, Lu W, Zhang H, Xu J. Li Y, et al. Among authors: cen y. Research (Wash D C). 2023;6:0070. doi: 10.34133/research.0070. Epub 2023 Mar 9. Research (Wash D C). 2023. PMID: 36930754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

828 results

Search Page

Filters